Literature DB >> 15660016

Increase in poisoning deaths caused by non-illicit drugs--Utah, 1991-2003.

.   

Abstract

Deaths caused by drug poisoning of unintentional and undetermined intent are an increasing problem in Utah and elsewhere in the United States. To characterize the trend in drug-poisoning deaths in Utah, CDC and the Utah Department of Health analyzed medical examiner (ME) data for 1991-1998 and 1999-2003. This report summarizes the results of that analysis, which determined that, during 1991-2003, the number of Utah residents dying from all drug poisoning increased nearly fivefold, from 79 deaths in 1991 (rate: 4.4 per 100,000 population) to 391 deaths in 2003 (rate: 16.6). This increase has been largely the result of the tripling of the rate (from 1.5 during 1991-1998 to 4.4 during 1999-2003) in poisoning deaths of unintentional or undetermined intent caused by non-illicit drugs (i.e., medications that can be legally prescribed). Further study is needed to understand these trends and to develop strategies to prevent deaths of unintentional or undetermined intent from non-illicit drug poisoning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660016

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  21 in total

1.  Development of a coroner-based surveillance system for drug-related deaths in Los Angeles county.

Authors:  Isabelle Sternfeld; Nicolle Perras; Patti L Culross
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

2.  Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Authors:  Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

3.  Opioid Overdose Hospitalization Trajectories in States With and Without Opioid-Dosing Guidelines.

Authors:  Jeanne M Sears; Deborah Fulton-Kehoe; Beryl A Schulman; Sheilah Hogg-Johnson; Gary M Franklin
Journal:  Public Health Rep       Date:  2019-07-31       Impact factor: 2.792

4.  The quest for stability in an unstable world: adaptive servoventilation in opioid induced complex sleep apnea syndrome.

Authors:  Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

5.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

6.  A novel adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids.

Authors:  Michelle Cao; Chia-Yu Cardell; Leslee Willes; June Mendoza; Adam Benjafield; Clete Kushida
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

7.  Adaptive servoventilation for treatment of opioid-associated central sleep apnea.

Authors:  Shahrokh Javaheri; Nicholas Harris; Joseph Howard; Eugene Chung
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

8.  Adaptive servoventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure.

Authors:  Kannan Ramar; Priya Ramar; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

9.  Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009.

Authors:  Erin M Johnson; William A Lanier; Ray M Merrill; Jacob Crook; Christina A Porucznik; Robert T Rolfs; Brian Sauer
Journal:  J Gen Intern Med       Date:  2012-10-16       Impact factor: 5.128

Review 10.  Are opioids associated with sleep apnea? A review of the evidence.

Authors:  James M Walker; Robert J Farney
Journal:  Curr Pain Headache Rep       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.